ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

MRVI Maravai LifeSciences Holdings Inc

8,42
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Maravai LifeSciences Holdings Inc MRVI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 8,42 10:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
8,42
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202422:49BWTriLink BioTechnologies® et Lonza signent un contrat de..
30.4.202413:31BWTriLink BioTechnologies® and Lonza Enter into Non-exclusive..
18.4.202421:12BWTriLink BioTechnologies® annonce un nouveau site à San Diego..
18.4.202421:09BWTriLink BioTechnologies® kündigt neue Anlage in San Diego..
18.4.202413:36BWTriLink BioTechnologies® Announces New San Diego Facility..
10.4.202422:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
12.3.202421:15GLOBEMaravai LifeSciences Announces March 2024 Investor..
29.2.202423:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.2.202422:08EDGAR2Form 8-K - Current report
22.2.202422:05GLOBEMaravai LifeSciences Reports Fourth Quarter and Full Year..
21.2.202414:00BWTriLink BioTechnologies® Solidifies IP Position with Awarded..
21.2.202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202414:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
08.2.202422:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29.1.202414:00GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
19.1.202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202400:15EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
16.11.202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202314:15GLOBEMaravai LifeSciences Announces November 2023 Investor..
08.11.202323:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:11EDGAR2Form 8-K - Current report
07.11.202322:05GLOBEMaravai LifeSciences Reports Third Quarter 2023 Financial..
02.11.202311:47BWTriLink BioTechnologies® Expands Capabilities with Launch of..
17.10.202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.10.202314:15GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
29.9.202314:15GLOBEMaravai LifeSciences Hosts 2023 Investor R&D Day
19.9.202315:31GLOBEMaravai LifeSciences Chief Innovation Officer Kate Broderick..
05.9.202322:15GLOBEMaravai LifeSciences to Host 2023 Investor R&D Day
23.8.202314:15GLOBECygnus Technologies Receives 2023 R&D 100 Award for MockV®..
22.8.202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202322:15GLOBEMaravai LifeSciences Announces August 2023 Investor..
08.8.202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202322:19EDGAR2Form 8-K - Current report
07.8.202322:05GLOBEMaravai LifeSciences Reports Second Quarter 2023 Financial..
27.7.202322:11EDGAR2Form 8-K - Current report
27.7.202322:05GLOBEMaravai LifeSciences Announces Completion of Planned CEO..
24.7.202322:05GLOBEMaravai LifeSciences To Host Earnings Conference Call on..
20.7.202322:08EDGAR2Form 8-K - Current report
20.7.202322:05GLOBEMaravai LifeSciences Announces Appointment of New Director..
19.7.202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.7.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.7.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.7.202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.7.202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.7.202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202314:00GLOBECongressman Scott Peters Tours Maravai’s RNA manufacturing..
24.5.202322:58BWトライリンク・バイオテクノロジーズ®が製造能力拡張を発表、mRNA製造施設が完成間近

Kürzlich von Ihnen besucht

Delayed Upgrade Clock